277 related articles for article (PubMed ID: 32871607)
1. Mannose-Binding Lectin is Associated with Thrombosis and Coagulopathy in Critically Ill COVID-19 Patients.
Eriksson O; Hultström M; Persson B; Lipcsey M; Ekdahl KN; Nilsson B; Frithiof R
Thromb Haemost; 2020 Dec; 120(12):1720-1724. PubMed ID: 32871607
[TBL] [Abstract][Full Text] [Related]
2. D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review.
Eljilany I; Elzouki AN
Vasc Health Risk Manag; 2020; 16():455-462. PubMed ID: 33223833
[TBL] [Abstract][Full Text] [Related]
3. Prospective Observational Study on the Association Between Serum Mannose-Binding Lectin Levels and Severe Outcome in Critically Ill Patients with Pandemic Influenza Type A (H1N1) Infection.
Zogheib E; Nyga R; Cornu M; Sendid B; Monconduit J; Jounieaux V; Maizel J; Segard C; Chouaki T; Dupont H
Lung; 2018 Feb; 196(1):65-72. PubMed ID: 29273833
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 Infection: Viral Macro- and Micro-Vascular Coagulopathy and Thromboembolism/Prophylactic and Therapeutic Management.
Manolis AS; Manolis TA; Manolis AA; Papatheou D; Melita H
J Cardiovasc Pharmacol Ther; 2021 Jan; 26(1):12-24. PubMed ID: 32924567
[TBL] [Abstract][Full Text] [Related]
5. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.
Helms J; Tacquard C; Severac F; Leonard-Lorant I; Ohana M; Delabranche X; Merdji H; Clere-Jehl R; Schenck M; Fagot Gandet F; Fafi-Kremer S; Castelain V; Schneider F; Grunebaum L; Anglés-Cano E; Sattler L; Mertes PM; Meziani F;
Intensive Care Med; 2020 Jun; 46(6):1089-1098. PubMed ID: 32367170
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.
Dujardin RWG; Hilderink BN; Haksteen WE; Middeldorp S; Vlaar APJ; Thachil J; Müller MCA; Juffermans NP
Thromb Res; 2020 Dec; 196():308-312. PubMed ID: 32977128
[TBL] [Abstract][Full Text] [Related]
7. Complement Alternative and Mannose-Binding Lectin Pathway Activation Is Associated With COVID-19 Mortality.
Defendi F; Leroy C; Epaulard O; Clavarino G; Vilotitch A; Le Marechal M; Jacob MC; Raskovalova T; Pernollet M; Le Gouellec A; Bosson JL; Poignard P; Roustit M; Thielens N; Dumestre-Pérard C; Cesbron JY
Front Immunol; 2021; 12():742446. PubMed ID: 34567008
[TBL] [Abstract][Full Text] [Related]
8. Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications.
Voicu S; Delrue M; Chousterman BG; Stépanian A; Bonnin P; Malissin I; Deye N; Neuwirth M; Ketfi C; Mebazaa A; Siguret V; Mégarbane B
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):9161-9168. PubMed ID: 32965009
[TBL] [Abstract][Full Text] [Related]
9. Hypercoagulopathy in Severe COVID-19: Implications for Acute Care.
Waite AAC; Hamilton DO; Pizzi R; Ageno W; Welters ID
Thromb Haemost; 2020 Dec; 120(12):1654-1667. PubMed ID: 33368088
[TBL] [Abstract][Full Text] [Related]
10. Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients.
Holter JC; Pischke SE; de Boer E; Lind A; Jenum S; Holten AR; Tonby K; Barratt-Due A; Sokolova M; Schjalm C; Chaban V; Kolderup A; Tran T; Tollefsrud Gjølberg T; Skeie LG; Hesstvedt L; Ormåsen V; Fevang B; Austad C; Müller KE; Fladeby C; Holberg-Petersen M; Halvorsen B; Müller F; Aukrust P; Dudman S; Ueland T; Andersen JT; Lund-Johansen F; Heggelund L; Dyrhol-Riise AM; Mollnes TE
Proc Natl Acad Sci U S A; 2020 Oct; 117(40):25018-25025. PubMed ID: 32943538
[TBL] [Abstract][Full Text] [Related]
11. Coagulation parameters and venous thromboembolism in patients with and without COVID-19 admitted to the Emergency Department for acute respiratory insufficiency.
Pizzi R; Gini G; Caiano L; Castelli B; Dotan N; Magni F; Virano A; Roveda A; Bertù L; Ageno W
Thromb Res; 2020 Dec; 196():209-212. PubMed ID: 32911392
[TBL] [Abstract][Full Text] [Related]
12. Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients.
Jonmarker S; Hollenberg J; Dahlberg M; Stackelberg O; Litorell J; Everhov ÅH; Järnbert-Pettersson H; Söderberg M; Grip J; Schandl A; Günther M; Cronhjort M
Crit Care; 2020 Nov; 24(1):653. PubMed ID: 33225952
[TBL] [Abstract][Full Text] [Related]
13. Major bleeding complications in critically ill patients with COVID-19 pneumonia.
Godier A; Clausse D; Meslin S; Bazine M; Lang E; Huche F; Cholley B; Hamada SR
J Thromb Thrombolysis; 2021 Jul; 52(1):18-21. PubMed ID: 33646501
[TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism in critically ill patients affected by ARDS related to COVID-19 in Northern-West Italy.
Longhitano Y; Racca F; Zanza C; Piccioni A; Audo A; Muncinelli M; Santi R; Kozel D; Geraci C; Taverna M; Bonato V; Cassini F; Franceschi F
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):9154-9160. PubMed ID: 32965007
[TBL] [Abstract][Full Text] [Related]
15. Changes in Mannose-Binding Lectin and Collectin Kidney 1 Levels in Sepsis Patients With and Without Disseminated Intravascular Coagulation.
Hayakawa M; Ohtani K; Wakamiya N
Clin Appl Thromb Hemost; 2019; 25():1076029618821189. PubMed ID: 30808212
[TBL] [Abstract][Full Text] [Related]
16. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels.
Hansen TK; Thiel S; Wouters PJ; Christiansen JS; Van den Berghe G
J Clin Endocrinol Metab; 2003 Mar; 88(3):1082-8. PubMed ID: 12629088
[TBL] [Abstract][Full Text] [Related]
17. Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19.
Peerschke EI; Valentino A; So RJ; Shulman S; Ravinder
Front Immunol; 2021; 12():716361. PubMed ID: 34491250
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays.
White D; MacDonald S; Edwards T; Bridgeman C; Hayman M; Sharp M; Cox-Morton S; Duff E; Mahajan S; Moore C; Kirk M; Williams R; Besser M; Thomas W
Int J Lab Hematol; 2021 Feb; 43(1):123-130. PubMed ID: 32892505
[TBL] [Abstract][Full Text] [Related]
19. Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action.
Kollias A; Kyriakoulis KG; Dimakakos E; Poulakou G; Stergiou GS; Syrigos K
Br J Haematol; 2020 Jun; 189(5):846-847. PubMed ID: 32304577
[TBL] [Abstract][Full Text] [Related]
20. [COVID-19: Coagulopathy and thrombosis].
Tazi Mezalek Z
Rev Med Interne; 2021 Feb; 42(2):93-100. PubMed ID: 33509669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
